The SURMOUNT-1 trial demonstrated that patients taking the highest dose of Tirzepatide (15 mg) lost an average of 22.5% of their initial body weight over 72 weeks, significantly outperforming the weight loss achieved with Semaglutide in comparable studies 20.
⚠️ For research purposes only. Not for human consumption.
Reviews
There are no reviews yet.